Suchergebnisse - "Kurbatova, Ekaterina"

PubPharm (9)

1

Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349)

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Pettit, A. | Phillips, P. | Kurbatova, E. | +20

2

Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Podany, A. | Pham, M. | Sizemore, E. | +22

3

Four-Month Rifapentine Regimens for Tuberculosis. Reply

enthalten in: The New England journal of medicine | 2022

von Phillips, P. | Kurbatova, E. | Dorman, S.

CommentOn: N Engl J Med. 2022 Mar 17;386(11):1095. - PMID 35294822

4

Interim Guidance : 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022

enthalten in: MMWR. Morbidity and mortality weekly report | 2022

von Carr, W. | Kurbatova, E. | Starks, A. | +3

5

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

enthalten in: The New England journal of medicine | 2021

von Dorman, S. | Nahid, P. | Kurbatova, E. | +130

CommentIn: N Engl J Med. 2021 May 6;384(18):1764-1765. - PMID 33951367

6

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

enthalten in: BMC infectious diseases | 2020

von Ershova, J. | Volchenkov, G. | Somova, T. | +9

7

Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion

enthalten in: The Journal of infectious diseases | 2020

von Click, E. | Kurbatova, E. | Alexander, H. | +5

8

High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis : Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial

enthalten in: Contemporary clinical trials | 2020

von Dorman, S. | Nahid, P. | Kurbatova, E. | +30

9

Prevalence of anti-tuberculosis drug resistance in foreign-born tuberculosis cases in the U.S. and in their countries of origin

enthalten in: PloS one | 2012

von Taylor, A. | Kurbatova, E. | Cegielski, J.

1
[1]